Quarterly report pursuant to Section 13 or 15(d)

BASIS OF PRESENTATION (Details Narrative)

v3.19.3
BASIS OF PRESENTATION (Details Narrative)
$ / shares in Units, $ in Thousands
9 Months Ended
Jul. 17, 2019
$ / shares
Jul. 15, 2019
shares
Sep. 30, 2019
USD ($)
$ / shares
Dec. 31, 2018
USD ($)
$ / shares
Variable Interest Entity [Line Items]        
Substantial doubt about ability to continue as a going concern within one year     true  
Cash and cash equivalent | $     $ 13,546 $ 17,080
Dividend declared date   Jul. 15, 2019    
Common stock, par value (in dollars per share) | $ / shares     $ 0.001 $ 0.001
Emmaus Life Sciences, Inc. [Member]        
Variable Interest Entity [Line Items]        
Reverse split 1-for-6      
Reverse split, conversion ratio 0.167      
Common stock, par value (in dollars per share) | $ / shares $ 0.001      
Telemynd [Member]        
Variable Interest Entity [Line Items]        
Common stock shares, Stock split ratio | shares   1    
EJ Holdings, Inc. [Member]        
Variable Interest Entity [Line Items]        
Cash and cash equivalent | $     $ 12,220 $ 13,175
Percentage of voting interest in variable interest entity     40.00%